The fundamental goal of the Center for Translational Biotechnology (“CTB”) is to function as a service entity. CTB aims to foster the advance of promising biologics, treatments, and new therapies, through partnership and co-development. To do this, CTB locates and provides the infrastructure, expertise and resources necessary to identify and evaluate innovative projects and programs at various stages of clinical translation. Additionally, CTB performs tests and offers support for preclinical investigation, clinical trial submission, and trial implementation.